CA3094420C - Progesterone intravaginal devices - Google Patents

Progesterone intravaginal devices Download PDF

Info

Publication number
CA3094420C
CA3094420C CA3094420A CA3094420A CA3094420C CA 3094420 C CA3094420 C CA 3094420C CA 3094420 A CA3094420 A CA 3094420A CA 3094420 A CA3094420 A CA 3094420A CA 3094420 C CA3094420 C CA 3094420C
Authority
CA
Canada
Prior art keywords
progesterone
ring
intravaginal
pharmaceutically acceptable
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3094420A
Other languages
English (en)
French (fr)
Other versions
CA3094420A1 (en
Inventor
Concepcion Nieto Magro
Elena Perez Hernando
Jaime Moscoso Del Prado
Javier Suarez Almarza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ITF Research Pharma SL
Original Assignee
ITF Research Pharma SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ITF Research Pharma SL filed Critical ITF Research Pharma SL
Publication of CA3094420A1 publication Critical patent/CA3094420A1/en
Application granted granted Critical
Publication of CA3094420C publication Critical patent/CA3094420C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
CA3094420A 2018-03-21 2019-03-21 Progesterone intravaginal devices Active CA3094420C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18382190.9 2018-03-21
EP18382190.9A EP3542786A1 (en) 2018-03-21 2018-03-21 Progesterone intravaginal devices
PCT/EP2019/057074 WO2019180133A1 (en) 2018-03-21 2019-03-21 Progesterone intravaginal devices

Publications (2)

Publication Number Publication Date
CA3094420A1 CA3094420A1 (en) 2019-09-26
CA3094420C true CA3094420C (en) 2024-06-25

Family

ID=61768237

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3094420A Active CA3094420C (en) 2018-03-21 2019-03-21 Progesterone intravaginal devices

Country Status (7)

Country Link
US (1) US11278491B2 (enExample)
EP (2) EP3542786A1 (enExample)
JP (1) JP7391863B2 (enExample)
KR (1) KR102844796B1 (enExample)
CN (1) CN112469392A (enExample)
CA (1) CA3094420C (enExample)
WO (1) WO2019180133A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3542786A1 (en) 2018-03-21 2019-09-25 ITF Research Pharma, S.L.U. Progesterone intravaginal devices
CN114126710A (zh) * 2019-03-29 2022-03-01 B·马特尔 含有孕酮的eva分段式阴道内环
CN121243071A (zh) * 2025-10-30 2026-01-02 南京帝昌医药科技有限公司 一种雌激素阴道泡沫剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816257A (en) * 1985-09-20 1989-03-28 Research & Education Institute, Harbor-Ucla Medical Center Inc. Method for producing an in vivo environment suitable for human embryo transfer
US5869081A (en) 1996-06-28 1999-02-09 The Population Council Progesterone vaginal ring for treatment of infertility
US6287693B1 (en) 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
ES2648640T3 (es) 2008-02-04 2018-01-04 Ferring B.V. Anillos intravaginales monolíticos que comprenden progesterona y métodos de fabricación y usos de los mismos
US20170224823A1 (en) 2014-10-22 2017-08-10 International Partnership For Microbicides, Inc. Platinum-catalyzed silicone drug delivery devices and methods of use thereof
EP3542786A1 (en) 2018-03-21 2019-09-25 ITF Research Pharma, S.L.U. Progesterone intravaginal devices

Also Published As

Publication number Publication date
CA3094420A1 (en) 2019-09-26
KR20200135443A (ko) 2020-12-02
WO2019180133A1 (en) 2019-09-26
CN112469392A (zh) 2021-03-09
JP7391863B2 (ja) 2023-12-05
KR102844796B1 (ko) 2025-08-08
EP3768235A1 (en) 2021-01-27
JP2021518405A (ja) 2021-08-02
US11278491B2 (en) 2022-03-22
RU2020131251A (ru) 2022-04-22
US20210030666A1 (en) 2021-02-04
EP3542786A1 (en) 2019-09-25

Similar Documents

Publication Publication Date Title
US20230158044A1 (en) Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
US11278491B2 (en) Progesterone intravaginal devices
WO2020205803A1 (en) Eva segmented intravaginal rings containing progesterone
RU2830189C2 (ru) Интравагинальные устройства, содержащие прогестерон
AU2016202114B2 (en) Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
AU2013203779B2 (en) Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
HK1150428B (en) Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
HK1150428A (en) Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220427

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 6TH ANNIV.) - STANDARD

Year of fee payment: 6

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250314

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250314

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250314

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 7TH ANNIV.) - STANDARD

Year of fee payment: 7

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260211

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260212